I had gotten in with my eyes open that this was a high risk high reward play, but I was concerned that I hadnt conveyed that clearly enough in the article
This shift reflects growing demand: clinical trials show GLP-1 receptor agonists produce average weight loss of 15-22% of body weight over 68 weeks
Of note, as the DKP produced possesses the same mass than AX, the cyclization of the antibiotic in the presence of thiol-containing compounds would remain undetected if monitored only by MS (Reyns et al., 2008)
butyricum , its key metabolic product SCFAs, and prebiotics exert distinct effects on various viruses in animal experiments
The complaint states: Defendants set on a course to create and expand the market for weight-loss medication by advocating for obesity to be classified as a disease and thereby expanding the market for their drugs...[they implemented] multifaceted marketing campaigns that were so effective they engrained these drugs in the pop culture zeitgeist, and spending untold millions in an effort to get weight-loss medications covered under public and private insurance
